v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:        
Net loss $ (2,061,740) $ (1,148,081) $ (7,640,973) $ (6,365,984)
Adjustments to reconcile net loss to net cash from operating activities:        
Depreciation and amortization expense 671 1,965 26,722 112,850
Change in fair value of derivatives 366,009 202,710 179,252 (161,122)
Change in fair value of contingent liabilities (174,675) 0 47,500 0
Loss on issuance of derivatives 1,086,158 17,676 2,068,536 191,162
Gain on extinguishment of derivative liability (28,573) (351,971) (1,431,541) (264,539)
Loss on impairment of assets     579,957 957,377
Loss on shutdown of Axenic     18,451 0
Loss on sale of Alvey oil field     1,241,110 0
Loss on investment in WTXR     147,435 0
Bad debt expense     123,076 0
Shares issued for services     0 267,500
Stock compensation 23,400 47,500 177,135 0
Warrants issued for services 0 28,987 28,987 53,991
Amortization of debt discount 225,493 228,449 933,116 294,222
Changes in operating assets and liabilities        
Prepaid expenses and other current assets 28,927 (48,574) 163,250 395,737
Contingent liabilities (15,325) (65,000) (100,000) 437,500
Accounts payable (63,360) (34,215) 272,227 222,587
Accounts payable - related parties 55,500 23,275  
Accrued interest 128,521 76,416 280,420 361,979
Net cash used in   operating activities from continuing operations (428,994) (1,020,863) (2,885,340) (3,496,740)
Cash flows from investing activities:        
Purchase of property and equipment 0 (87,350) (861,350) (338,001)
Cash issued for deposit on asset     (100,000) 0
Issuance of loan receivable 0 (5,000) (25,000) (90,000)
Cash received from non-controlling interest contribution     0 120,000
Net cash used in   investing activities from continuing operations 0 (92,350) (986,350) (308,001)
Cash flows used financing activities:        
Shares issued for cash 137,192 0 200,000 0
Proceeds from issuance of common stock     0 150,000
Proceeds from notes payable 64,064 400,000 517,562 183,061
Proceeds from convertible notes payable 495,000 922,500 3,570,800 2,582,650
Proceeds from related party convertible notes payable 65,600 0  
Proceeds from notes payable, related party     14,482 0
Repayment of convertible notes payable (104,075) (104,338) (284,313) (277,638)
Repayment of notes payable (12,681) (68,500) (129,242) (95,000)
Repayment of notes payable from related party (3,000) 0  
Net cash provided by   financing activities from continuing operations 642,100 1,149,662 3,889,289 2,543,073
Net change in cash and cash equivalents from continuing operations 213,106 36,449 17,599 (1,261,668)
Cash flow from discontinued operations:        
Net cash from operating activities from discontinued operations 0 2,616 (26,780) 1,301,882
Net cash from financing activities from discontinued operations 0 0 (0) (0)
Net cash from investing activities from discontinued operations 0 0 0 (220,220)
Net change in cash and cash equivalents from discontinued operations 0 2,616 (26,780) 1,081,662
Net change in cash and cash equivalents     (9,181) (180,006)
Cash and cash equivalents at beginning of year 50,230 59,411 59,411 239,417
Cash and cash equivalents at end of period 263,336 98,476 50,230 59,411
Cash paid during the period for:        
Interest 19,156 0 19,156 0
Income taxes 0 0    
Supplemental Disclosure of Non-Cash Investing and Financing Activities:        
Shares issued for conversion of convertible notes payable and accrued interest 121,178 961,193 4,139,034 1,695,000
Shares issued for deposit on distribution and manufacturing agreement 600,000 0    
Shares issued for accrued interest     268,360 253,842
Shares issued for contingent liability     195,000 0
Derivative liability 1,570,758 56,585 1,035,000 0
Shares issued for stock price guarantee 15,325 0    
Debt discount 529,600 0    
Preferred to common stock exchange $ 19,404 $ 0    
Debt discount on convertible notes payable     $ (1,504,245) $ 337,889